Literature DB >> 15872225

Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital.

E Bouza1, J Guinea, T Peláez, J Pérez-Molina, L Alcalá, P Muñoz.   

Abstract

The increase in the immunocompromised population and the incidence of invasive aspergillosis (IA) are leading to an overinterpretation of the potential clinical significance of many isolates of Aspergillus fumigatus. Our work prospectively assesses the workload of the isolation of A. fumigatus and its clinical significance in the microbiology laboratory of a large teaching hospital. During a 3-year period, all patients from whom A. fumigatus was isolated were prospectively monitored and classified as having IA or "nonsignificant" disease. A point score based on the prediction of five easily obtained laboratory and clinical parameters was applied. We found 404 A. fumigatus isolates in 260 patients (1/1,000 microbiology laboratory samples; 2.1 patients/10,000 admissions). A total of 90 isolates (22.3%) were from patients with IA. Of the 260 patients, 31 (12%) had invasive disease (IA), and the remaining 229 had "nonsignificant" disease. A score based on points for five parameters was applied to our population. It was constructed as follows: "sample obtained by invasive procedures" (1 point), "presence of two or more positive samples from the same patient" (1 point), "leukemia" (2 points), "neutropenia" (5 points), and "corticosteroid treatment" (2 points). Patients with a score of 0 had only a 2.5% probability of IA. Those with a score of 1 or 2 had an increased probability of 10.3%. The probabilities rose to 40% and 70%, respectively, for patients with a score of 3 or 4 or a score of > or = 5. A simple score based on five easily available parameters may be of help to microbiologists and clinicians to predict the risk of IA.

Entities:  

Mesh:

Year:  2005        PMID: 15872225      PMCID: PMC1153778          DOI: 10.1128/JCM.43.5.2075-2079.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Aspergillus antigen testing in bone marrow transplant recipients.

Authors:  E C Williamson; D A Oliver; E M Johnson; A B Foot; D I Marks; D W Warnock
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

Review 2.  The clinical spectrum of pulmonary aspergillosis.

Authors:  Ayman O Soubani; Pranatharthi H Chandrasekar
Journal:  Chest       Date:  2002-06       Impact factor: 9.410

3.  Invasive aspergillosis: current and future challenges in diagnosis and therapy.

Authors:  W W Hope; D W Denning
Journal:  Clin Microbiol Infect       Date:  2004-01       Impact factor: 8.067

4.  Aspergillus infection complicating cardiac transplantation. Report of five cases.

Authors:  M J Gurwith; E B Stinson; J S Remington
Journal:  Arch Intern Med       Date:  1971-10

5.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Authors:  S Ascioglu; J H Rex; B de Pauw; J E Bennett; J Bille; F Crokaert; D W Denning; J P Donnelly; J E Edwards; Z Erjavec; D Fiere; O Lortholary; J Maertens; J F Meis; T F Patterson; J Ritter; D Selleslag; P M Shah; D A Stevens; T J Walsh
Journal:  Clin Infect Dis       Date:  2001-11-26       Impact factor: 9.079

6.  Invasive aspergillosis in cancer.

Authors:  H Sridhar; R S Jayshree; P P Bapsy; L Appaji; M Navin Kumar; M Shafiulla; B R VijayKumar
Journal:  Mycoses       Date:  2002-11       Impact factor: 4.377

7.  Invasive aspergillosis in critically ill patients without malignancy.

Authors:  Wouter Meersseman; Stefaan J Vandecasteele; Alexander Wilmer; Eric Verbeken; Willy E Peetermans; Eric Van Wijngaerden
Journal:  Am J Respir Crit Care Med       Date:  2004-06-30       Impact factor: 21.405

8.  Invasive aspergillosis. Progress in early diagnosis and treatment.

Authors:  B D Fisher; D Armstrong; B Yu; J W Gold
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

9.  Invasive aspergillosis. Clinical features of 35 proven cases at a single institution.

Authors:  L Kaiser; T Huguenin; P D Lew; B Chapuis; D Pittet
Journal:  Medicine (Baltimore)       Date:  1998-05       Impact factor: 1.889

Review 10.  Rapid diagnosis of invasive aspergillosis by antigen detection.

Authors:  L J Wheat
Journal:  Transpl Infect Dis       Date:  2003-12       Impact factor: 2.228

View more
  14 in total

1.  Microsatellite (STRAf) genotyping cannot differentiate between invasive and colonizing Aspergillus fumigatus isolates.

Authors:  Pilar Escribano; Teresa Peláez; Emilio Bouza; Jesús Guinea
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

2.  Assessment of the significance of respiratory culture of Aspergillus in the non-neutropenic patient. A critique of published diagnostic criteria.

Authors:  R C Barton; R P Hobson; H McLoughlin; A Morris; B Datta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-01       Impact factor: 3.267

Review 3.  Current challenges in the microbiological diagnosis of invasive aspergillosis.

Authors:  Jesús Guinea; Emilio Bouza
Journal:  Mycopathologia       Date:  2014-06-20       Impact factor: 2.574

4.  Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection?

Authors:  Jose Barberan; Bernardino Alcazar; Eduardo Malmierca; Francisco Garcia de la Llana; Jordi Dorca; Daniel Del Castillo; Victoria Villena; Melissa Hernandez-Febles; Francisco-Javier Garcia-Perez; Juan-Jose Granizo; Maria-Jose Gimenez; Lorenzo Aguilar
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090

5.  Two cases of aspergillus endocarditis in non neutropenic children on chemotherapy for acute lymphoblastic leukaemia.

Authors:  Emmanouil Nikolousis; Mark Velangi
Journal:  Hematol Rep       Date:  2011-06-30

6.  Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients.

Authors:  Koenraad H Vandewoude; Stijn I Blot; Pieter Depuydt; Dominique Benoit; Werner Temmerman; Francis Colardyn; Dirk Vogelaers
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

7.  Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes.

Authors:  Fabio Silvio Taccone; Anne-Marie Van den Abeele; Pierre Bulpa; Benoit Misset; Wouter Meersseman; Teresa Cardoso; José-Artur Paiva; Miguel Blasco-Navalpotro; Emmanuel De Laere; George Dimopoulos; Jordi Rello; Dirk Vogelaers; Stijn I Blot
Journal:  Crit Care       Date:  2015-01-12       Impact factor: 9.097

Review 8.  Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.

Authors:  Florence Ader; Anne-Lise Bienvenu; Blandine Rammaert; Saad Nseir
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-08-03

Review 9.  A validated clinical approach for the management of aspergillosis in critically ill patients: ready, steady, go!

Authors:  Jose Garnacho-Montero; Rosario Amaya-Villar
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

10.  Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study.

Authors:  Arturo Huerta; Nestor Soler; Mariano Esperatti; Mónica Guerrero; Rosario Menendez; Alexandra Gimeno; Rafael Zalacaín; Nuria Mir; Jose Maria Aguado; Antoni Torres
Journal:  Respir Res       Date:  2014-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.